Clinical Trial Update: Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the University of Kansas Medical Center is evaluating whether adding losartan to modulator therapy can reduce inflammation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Cystic Fibrosis | Phase 2 | Status: RECRUITING